摘要
Background: Transcatheter aortic valve replacement (TAVR) is an established therapy in high-risk patients with severe aortic stenosis. Among patients with reduced left ventricular ejection fraction (LVEF), it is unclear which patients will derive maximal benefit from TAVR. Methods: Clinical and echocardiographic data of patients with severe aortic stenosis and low LVEF (= 10%) versus persistent LV dysfunction (Group B=Delta LVEF= 10% in 50% of patients following the procedure (Group B). At baseline echocardiograms, Group B had higher LVEF, stroke volume (SV), SV index; and lower E, E/E', and estimated pulmonary arterial systolic pressure (PASP) compared to Group A. Higher mortality was found in Group B compared to the Group A (p=0.003) with a significantly shorter survival (Group A=3.3 +/- 0.1years vs Group B=2.7 +/- 0.2years, p=0.003). One-year event free survival was 53.3% in Group B compared to 93.3% in Group A, with a stable trend over ensuing years (5-year survival; 53.3% versus 90.0%, p=0.003). Conclusions: In patients undergoing TAVR with depressed LV function, those who failed to improve were more likely to have relatively higher LVEF, SV, and SVI; and lower E, E/E', and PASP at baseline. Mortality rates were found to be higher in persistent LV dysfunction group. (C) 2015 Wiley Periodicals, Inc.
| 源语言 | 英语 |
|---|---|
| 页(从-至) | 1164-1172 |
| 页数 | 9 |
| 期刊 | Catheterization and Cardiovascular Interventions |
| 卷 | 87 |
| 期 | 6 |
| DOI | |
| 出版状态 | 已出版 - 5月 2016 |
基金资助
Dr. Heisnianri received research funding from Edwards Lifesciences.
关键词
- transcatheter aortic valve replacement
- echocardiography
- left ventricular function
- survival post-TAVR
收录
- SCIE
学术指纹
探究 'Echocardiographic Determinants of LV Functional Improvement After Transcatheter Aortic Valve Replacement' 的科研主题。它们共同构成独一无二的学术指纹。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver